["[{\"group1\":\"TRTA\",\"group1_level\":\"Placebo\",\"group2\":\"AEBODSYS\",\"group2_level\":\"GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS\",\"variable\":\"AEDECOD\",\"variable_level\":\"APPLICATION SITE DERMATITIS\",\"stat_name\":\"n\",\"stat_label\":\"n\",\"stat\":5},{\"group1\":\"TRTA\",\"group1_level\":\"Placebo\",\"group2\":\"AEBODSYS\",\"group2_level\":\"GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS\",\"variable\":\"AEDECOD\",\"variable_level\":\"APPLICATION SITE DERMATITIS\",\"stat_name\":\"N\",\"stat_label\":\"N\",\"stat\":86},{\"group1\":\"TRTA\",\"group1_level\":\"Placebo\",\"group2\":\"AEBODSYS\",\"group2_level\":\"GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS\",\"variable\":\"AEDECOD\",\"variable_level\":\"APPLICATION SITE DERMATITIS\",\"stat_name\":\"p\",\"stat_label\":\"%\",\"stat\":0.0581},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline High Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS\",\"variable\":\"AEDECOD\",\"variable_level\":\"APPLICATION SITE DERMATITIS\",\"stat_name\":\"n\",\"stat_label\":\"n\",\"stat\":7},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline High Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS\",\"variable\":\"AEDECOD\",\"variable_level\":\"APPLICATION SITE DERMATITIS\",\"stat_name\":\"N\",\"stat_label\":\"N\",\"stat\":84},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline High Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS\",\"variable\":\"AEDECOD\",\"variable_level\":\"APPLICATION SITE DERMATITIS\",\"stat_name\":\"p\",\"stat_label\":\"%\",\"stat\":0.0833},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline Low Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS\",\"variable\":\"AEDECOD\",\"variable_level\":\"APPLICATION SITE DERMATITIS\",\"stat_name\":\"n\",\"stat_label\":\"n\",\"stat\":9},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline Low Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS\",\"variable\":\"AEDECOD\",\"variable_level\":\"APPLICATION SITE DERMATITIS\",\"stat_name\":\"N\",\"stat_label\":\"N\",\"stat\":84},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline Low Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS\",\"variable\":\"AEDECOD\",\"variable_level\":\"APPLICATION SITE DERMATITIS\",\"stat_name\":\"p\",\"stat_label\":\"%\",\"stat\":0.1071},{\"group1\":\"TRTA\",\"group1_level\":\"Placebo\",\"group2\":\"AEBODSYS\",\"group2_level\":\"GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS\",\"variable\":\"AEDECOD\",\"variable_level\":\"APPLICATION SITE ERYTHEMA\",\"stat_name\":\"n\",\"stat_label\":\"n\",\"stat\":3},{\"group1\":\"TRTA\",\"group1_level\":\"Placebo\",\"group2\":\"AEBODSYS\",\"group2_level\":\"GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS\",\"variable\":\"AEDECOD\",\"variable_level\":\"APPLICATION SITE ERYTHEMA\",\"stat_name\":\"N\",\"stat_label\":\"N\",\"stat\":86},{\"group1\":\"TRTA\",\"group1_level\":\"Placebo\",\"group2\":\"AEBODSYS\",\"group2_level\":\"GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS\",\"variable\":\"AEDECOD\",\"variable_level\":\"APPLICATION SITE ERYTHEMA\",\"stat_name\":\"p\",\"stat_label\":\"%\",\"stat\":0.0349},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline High Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS\",\"variable\":\"AEDECOD\",\"variable_level\":\"APPLICATION SITE ERYTHEMA\",\"stat_name\":\"n\",\"stat_label\":\"n\",\"stat\":15},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline High Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS\",\"variable\":\"AEDECOD\",\"variable_level\":\"APPLICATION SITE ERYTHEMA\",\"stat_name\":\"N\",\"stat_label\":\"N\",\"stat\":84},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline High Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS\",\"variable\":\"AEDECOD\",\"variable_level\":\"APPLICATION SITE ERYTHEMA\",\"stat_name\":\"p\",\"stat_label\":\"%\",\"stat\":0.1786},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline Low Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS\",\"variable\":\"AEDECOD\",\"variable_level\":\"APPLICATION SITE ERYTHEMA\",\"stat_name\":\"n\",\"stat_label\":\"n\",\"stat\":12},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline Low Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS\",\"variable\":\"AEDECOD\",\"variable_level\":\"APPLICATION SITE ERYTHEMA\",\"stat_name\":\"N\",\"stat_label\":\"N\",\"stat\":84},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline Low Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS\",\"variable\":\"AEDECOD\",\"variable_level\":\"APPLICATION SITE ERYTHEMA\",\"stat_name\":\"p\",\"stat_label\":\"%\",\"stat\":0.1429},{\"group1\":\"TRTA\",\"group1_level\":\"Placebo\",\"group2\":\"AEBODSYS\",\"group2_level\":\"GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS\",\"variable\":\"AEDECOD\",\"variable_level\":\"APPLICATION SITE IRRITATION\",\"stat_name\":\"n\",\"stat_label\":\"n\",\"stat\":3},{\"group1\":\"TRTA\",\"group1_level\":\"Placebo\",\"group2\":\"AEBODSYS\",\"group2_level\":\"GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS\",\"variable\":\"AEDECOD\",\"variable_level\":\"APPLICATION SITE IRRITATION\",\"stat_name\":\"N\",\"stat_label\":\"N\",\"stat\":86},{\"group1\":\"TRTA\",\"group1_level\":\"Placebo\",\"group2\":\"AEBODSYS\",\"group2_level\":\"GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS\",\"variable\":\"AEDECOD\",\"variable_level\":\"APPLICATION SITE IRRITATION\",\"stat_name\":\"p\",\"stat_label\":\"%\",\"stat\":0.0349},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline High Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS\",\"variable\":\"AEDECOD\",\"variable_level\":\"APPLICATION SITE IRRITATION\",\"stat_name\":\"n\",\"stat_label\":\"n\",\"stat\":9},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline High Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS\",\"variable\":\"AEDECOD\",\"variable_level\":\"APPLICATION SITE IRRITATION\",\"stat_name\":\"N\",\"stat_label\":\"N\",\"stat\":84},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline High Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS\",\"variable\":\"AEDECOD\",\"variable_level\":\"APPLICATION SITE IRRITATION\",\"stat_name\":\"p\",\"stat_label\":\"%\",\"stat\":0.1071},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline Low Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS\",\"variable\":\"AEDECOD\",\"variable_level\":\"APPLICATION SITE IRRITATION\",\"stat_name\":\"n\",\"stat_label\":\"n\",\"stat\":9},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline Low Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS\",\"variable\":\"AEDECOD\",\"variable_level\":\"APPLICATION SITE IRRITATION\",\"stat_name\":\"N\",\"stat_label\":\"N\",\"stat\":84},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline Low Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS\",\"variable\":\"AEDECOD\",\"variable_level\":\"APPLICATION SITE IRRITATION\",\"stat_name\":\"p\",\"stat_label\":\"%\",\"stat\":0.1071},{\"group1\":\"TRTA\",\"group1_level\":\"Placebo\",\"group2\":\"AEBODSYS\",\"group2_level\":\"GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS\",\"variable\":\"AEDECOD\",\"variable_level\":\"APPLICATION SITE PRURITUS\",\"stat_name\":\"n\",\"stat_label\":\"n\",\"stat\":6},{\"group1\":\"TRTA\",\"group1_level\":\"Placebo\",\"group2\":\"AEBODSYS\",\"group2_level\":\"GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS\",\"variable\":\"AEDECOD\",\"variable_level\":\"APPLICATION SITE PRURITUS\",\"stat_name\":\"N\",\"stat_label\":\"N\",\"stat\":86},{\"group1\":\"TRTA\",\"group1_level\":\"Placebo\",\"group2\":\"AEBODSYS\",\"group2_level\":\"GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS\",\"variable\":\"AEDECOD\",\"variable_level\":\"APPLICATION SITE PRURITUS\",\"stat_name\":\"p\",\"stat_label\":\"%\",\"stat\":0.0698},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline High Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS\",\"variable\":\"AEDECOD\",\"variable_level\":\"APPLICATION SITE PRURITUS\",\"stat_name\":\"n\",\"stat_label\":\"n\",\"stat\":22},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline High Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS\",\"variable\":\"AEDECOD\",\"variable_level\":\"APPLICATION SITE PRURITUS\",\"stat_name\":\"N\",\"stat_label\":\"N\",\"stat\":84},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline High Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS\",\"variable\":\"AEDECOD\",\"variable_level\":\"APPLICATION SITE PRURITUS\",\"stat_name\":\"p\",\"stat_label\":\"%\",\"stat\":0.2619},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline Low Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS\",\"variable\":\"AEDECOD\",\"variable_level\":\"APPLICATION SITE PRURITUS\",\"stat_name\":\"n\",\"stat_label\":\"n\",\"stat\":22},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline Low Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS\",\"variable\":\"AEDECOD\",\"variable_level\":\"APPLICATION SITE PRURITUS\",\"stat_name\":\"N\",\"stat_label\":\"N\",\"stat\":84},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline Low Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS\",\"variable\":\"AEDECOD\",\"variable_level\":\"APPLICATION SITE PRURITUS\",\"stat_name\":\"p\",\"stat_label\":\"%\",\"stat\":0.2619},{\"group1\":\"TRTA\",\"group1_level\":\"Placebo\",\"group2\":\"AEBODSYS\",\"group2_level\":\"NERVOUS SYSTEM DISORDERS\",\"variable\":\"AEDECOD\",\"variable_level\":\"DIZZINESS\",\"stat_name\":\"n\",\"stat_label\":\"n\",\"stat\":2},{\"group1\":\"TRTA\",\"group1_level\":\"Placebo\",\"group2\":\"AEBODSYS\",\"group2_level\":\"NERVOUS SYSTEM DISORDERS\",\"variable\":\"AEDECOD\",\"variable_level\":\"DIZZINESS\",\"stat_name\":\"N\",\"stat_label\":\"N\",\"stat\":86},{\"group1\":\"TRTA\",\"group1_level\":\"Placebo\",\"group2\":\"AEBODSYS\",\"group2_level\":\"NERVOUS SYSTEM DISORDERS\",\"variable\":\"AEDECOD\",\"variable_level\":\"DIZZINESS\",\"stat_name\":\"p\",\"stat_label\":\"%\",\"stat\":0.0233},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline High Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"NERVOUS SYSTEM DISORDERS\",\"variable\":\"AEDECOD\",\"variable_level\":\"DIZZINESS\",\"stat_name\":\"n\",\"stat_label\":\"n\",\"stat\":11},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline High Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"NERVOUS SYSTEM DISORDERS\",\"variable\":\"AEDECOD\",\"variable_level\":\"DIZZINESS\",\"stat_name\":\"N\",\"stat_label\":\"N\",\"stat\":84},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline High Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"NERVOUS SYSTEM DISORDERS\",\"variable\":\"AEDECOD\",\"variable_level\":\"DIZZINESS\",\"stat_name\":\"p\",\"stat_label\":\"%\",\"stat\":0.131},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline Low Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"NERVOUS SYSTEM DISORDERS\",\"variable\":\"AEDECOD\",\"variable_level\":\"DIZZINESS\",\"stat_name\":\"n\",\"stat_label\":\"n\",\"stat\":8},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline Low Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"NERVOUS SYSTEM DISORDERS\",\"variable\":\"AEDECOD\",\"variable_level\":\"DIZZINESS\",\"stat_name\":\"N\",\"stat_label\":\"N\",\"stat\":84},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline Low Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"NERVOUS SYSTEM DISORDERS\",\"variable\":\"AEDECOD\",\"variable_level\":\"DIZZINESS\",\"stat_name\":\"p\",\"stat_label\":\"%\",\"stat\":0.0952},{\"group1\":\"TRTA\",\"group1_level\":\"Placebo\",\"group2\":\"AEBODSYS\",\"group2_level\":\"SKIN AND SUBCUTANEOUS TISSUE DISORDERS\",\"variable\":\"AEDECOD\",\"variable_level\":\"ERYTHEMA\",\"stat_name\":\"n\",\"stat_label\":\"n\",\"stat\":8},{\"group1\":\"TRTA\",\"group1_level\":\"Placebo\",\"group2\":\"AEBODSYS\",\"group2_level\":\"SKIN AND SUBCUTANEOUS TISSUE DISORDERS\",\"variable\":\"AEDECOD\",\"variable_level\":\"ERYTHEMA\",\"stat_name\":\"N\",\"stat_label\":\"N\",\"stat\":86},{\"group1\":\"TRTA\",\"group1_level\":\"Placebo\",\"group2\":\"AEBODSYS\",\"group2_level\":\"SKIN AND SUBCUTANEOUS TISSUE DISORDERS\",\"variable\":\"AEDECOD\",\"variable_level\":\"ERYTHEMA\",\"stat_name\":\"p\",\"stat_label\":\"%\",\"stat\":0.093},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline High Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"SKIN AND SUBCUTANEOUS TISSUE DISORDERS\",\"variable\":\"AEDECOD\",\"variable_level\":\"ERYTHEMA\",\"stat_name\":\"n\",\"stat_label\":\"n\",\"stat\":14},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline High Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"SKIN AND SUBCUTANEOUS TISSUE DISORDERS\",\"variable\":\"AEDECOD\",\"variable_level\":\"ERYTHEMA\",\"stat_name\":\"N\",\"stat_label\":\"N\",\"stat\":84},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline High Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"SKIN AND SUBCUTANEOUS TISSUE DISORDERS\",\"variable\":\"AEDECOD\",\"variable_level\":\"ERYTHEMA\",\"stat_name\":\"p\",\"stat_label\":\"%\",\"stat\":0.1667},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline Low Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"SKIN AND SUBCUTANEOUS TISSUE DISORDERS\",\"variable\":\"AEDECOD\",\"variable_level\":\"ERYTHEMA\",\"stat_name\":\"n\",\"stat_label\":\"n\",\"stat\":14},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline Low Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"SKIN AND SUBCUTANEOUS TISSUE DISORDERS\",\"variable\":\"AEDECOD\",\"variable_level\":\"ERYTHEMA\",\"stat_name\":\"N\",\"stat_label\":\"N\",\"stat\":84},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline Low Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"SKIN AND SUBCUTANEOUS TISSUE DISORDERS\",\"variable\":\"AEDECOD\",\"variable_level\":\"ERYTHEMA\",\"stat_name\":\"p\",\"stat_label\":\"%\",\"stat\":0.1667},{\"group1\":\"TRTA\",\"group1_level\":\"Placebo\",\"group2\":\"AEBODSYS\",\"group2_level\":\"SKIN AND SUBCUTANEOUS TISSUE DISORDERS\",\"variable\":\"AEDECOD\",\"variable_level\":\"PRURITUS\",\"stat_name\":\"n\",\"stat_label\":\"n\",\"stat\":8},{\"group1\":\"TRTA\",\"group1_level\":\"Placebo\",\"group2\":\"AEBODSYS\",\"group2_level\":\"SKIN AND SUBCUTANEOUS TISSUE DISORDERS\",\"variable\":\"AEDECOD\",\"variable_level\":\"PRURITUS\",\"stat_name\":\"N\",\"stat_label\":\"N\",\"stat\":86},{\"group1\":\"TRTA\",\"group1_level\":\"Placebo\",\"group2\":\"AEBODSYS\",\"group2_level\":\"SKIN AND SUBCUTANEOUS TISSUE DISORDERS\",\"variable\":\"AEDECOD\",\"variable_level\":\"PRURITUS\",\"stat_name\":\"p\",\"stat_label\":\"%\",\"stat\":0.093},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline High Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"SKIN AND SUBCUTANEOUS TISSUE DISORDERS\",\"variable\":\"AEDECOD\",\"variable_level\":\"PRURITUS\",\"stat_name\":\"n\",\"stat_label\":\"n\",\"stat\":26},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline High Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"SKIN AND SUBCUTANEOUS TISSUE DISORDERS\",\"variable\":\"AEDECOD\",\"variable_level\":\"PRURITUS\",\"stat_name\":\"N\",\"stat_label\":\"N\",\"stat\":84},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline High Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"SKIN AND SUBCUTANEOUS TISSUE DISORDERS\",\"variable\":\"AEDECOD\",\"variable_level\":\"PRURITUS\",\"stat_name\":\"p\",\"stat_label\":\"%\",\"stat\":0.3095},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline Low Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"SKIN AND SUBCUTANEOUS TISSUE DISORDERS\",\"variable\":\"AEDECOD\",\"variable_level\":\"PRURITUS\",\"stat_name\":\"n\",\"stat_label\":\"n\",\"stat\":21},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline Low Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"SKIN AND SUBCUTANEOUS TISSUE DISORDERS\",\"variable\":\"AEDECOD\",\"variable_level\":\"PRURITUS\",\"stat_name\":\"N\",\"stat_label\":\"N\",\"stat\":84},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline Low Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"SKIN AND SUBCUTANEOUS TISSUE DISORDERS\",\"variable\":\"AEDECOD\",\"variable_level\":\"PRURITUS\",\"stat_name\":\"p\",\"stat_label\":\"%\",\"stat\":0.25},{\"group1\":\"TRTA\",\"group1_level\":\"Placebo\",\"group2\":\"AEBODSYS\",\"group2_level\":\"SKIN AND SUBCUTANEOUS TISSUE DISORDERS\",\"variable\":\"AEDECOD\",\"variable_level\":\"RASH\",\"stat_name\":\"n\",\"stat_label\":\"n\",\"stat\":5},{\"group1\":\"TRTA\",\"group1_level\":\"Placebo\",\"group2\":\"AEBODSYS\",\"group2_level\":\"SKIN AND SUBCUTANEOUS TISSUE DISORDERS\",\"variable\":\"AEDECOD\",\"variable_level\":\"RASH\",\"stat_name\":\"N\",\"stat_label\":\"N\",\"stat\":86},{\"group1\":\"TRTA\",\"group1_level\":\"Placebo\",\"group2\":\"AEBODSYS\",\"group2_level\":\"SKIN AND SUBCUTANEOUS TISSUE DISORDERS\",\"variable\":\"AEDECOD\",\"variable_level\":\"RASH\",\"stat_name\":\"p\",\"stat_label\":\"%\",\"stat\":0.0581},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline High Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"SKIN AND SUBCUTANEOUS TISSUE DISORDERS\",\"variable\":\"AEDECOD\",\"variable_level\":\"RASH\",\"stat_name\":\"n\",\"stat_label\":\"n\",\"stat\":9},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline High Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"SKIN AND SUBCUTANEOUS TISSUE DISORDERS\",\"variable\":\"AEDECOD\",\"variable_level\":\"RASH\",\"stat_name\":\"N\",\"stat_label\":\"N\",\"stat\":84},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline High Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"SKIN AND SUBCUTANEOUS TISSUE DISORDERS\",\"variable\":\"AEDECOD\",\"variable_level\":\"RASH\",\"stat_name\":\"p\",\"stat_label\":\"%\",\"stat\":0.1071},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline Low Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"SKIN AND SUBCUTANEOUS TISSUE DISORDERS\",\"variable\":\"AEDECOD\",\"variable_level\":\"RASH\",\"stat_name\":\"n\",\"stat_label\":\"n\",\"stat\":13},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline Low Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"SKIN AND SUBCUTANEOUS TISSUE DISORDERS\",\"variable\":\"AEDECOD\",\"variable_level\":\"RASH\",\"stat_name\":\"N\",\"stat_label\":\"N\",\"stat\":84},{\"group1\":\"TRTA\",\"group1_level\":\"Xanomeline Low Dose\",\"group2\":\"AEBODSYS\",\"group2_level\":\"SKIN AND SUBCUTANEOUS TISSUE DISORDERS\",\"variable\":\"AEDECOD\",\"variable_level\":\"RASH\",\"stat_name\":\"p\",\"stat_label\":\"%\",\"stat\":0.1548}]"]
